Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Database
Language
Publication year range
1.
World J Pediatr Congenit Heart Surg ; 10(6): 709-714, 2019 11.
Article in English | MEDLINE | ID: mdl-31701840

ABSTRACT

OBJECTIVES: Junctional ectopic tachycardia (JET) is a relatively common narrow complex rhythm typically characterized by atrioventricular dissociation or retrograde atrial conduction in a 1:1 pattern. Junctional ectopic tachycardia can be a life-threatening disorder, causing severe hemodynamic compromise and increased morbidity and mortality. The treatment of refractory JET can be very difficult, even with multimodal therapeutic interventions. The purpose of this study was to assess the role of ivabradine in cases of JET refractory to amiodarone and esmolol. METHODS: A total of 480 congenital heart surgeries were carried out at our center in 2017. Twenty (4.16%) patients had postoperative JET. Among these, five infants, aged 7 to 12 months (median: 8 months), had refractory JET. These patients (three tetralogy of Fallot, one ventricular septal defect, one complete atrioventricular septal defect) were treated with oral ivabradine in the dose range of 0.1 to 0.2 mg/kg/12 h as an adjunct to amiodarone. RESULTS: All five patients achieved rate reduction and eventual conversion to sinus rhythm. Mean duration to achieve heart rate of <140 bpm after initiation of ivabradine therapy was 16.8 hours (±7.2 hours), while mean duration to achieve sinus rhythm was 31.6 hours (±13.6 hours). No patient had any recurrence of JET. No patient exhibited any hemodynamic derangement nor side effects attributable to oral ivabradine. CONCLUSION: Oral ivabradine has the potential to be used as an adjunct to amiodarone in the treatment of JET in infants after surgery for congenital heart disease.


Subject(s)
Cardiac Surgical Procedures/adverse effects , Heart Defects, Congenital/surgery , Heart Rate/drug effects , Ivabradine/therapeutic use , Postoperative Complications/drug therapy , Tachycardia, Ectopic Junctional/drug therapy , Cardiovascular Agents/therapeutic use , Electrocardiography , Female , Humans , Infant , Male , Postoperative Complications/etiology , Retrospective Studies , Tachycardia, Ectopic Junctional/etiology , Treatment Outcome
2.
Indian Heart J ; 69(5): 666-667, 2017.
Article in English | MEDLINE | ID: mdl-29054199

ABSTRACT

We report two cases of malignant junctional ectopic tachycardia (JET), in infants following congenital heart surgery. After the failure of conventional therapy the arrhythmia was controlled by oral Ivabradine, a drug which is routinely used to lower heart rate in angina and heart failure in adult practice.


Subject(s)
Benzazepines/therapeutic use , Cardiac Surgical Procedures/adverse effects , Electrocardiography/drug effects , Heart Defects, Congenital/surgery , Tachycardia, Ectopic Junctional/drug therapy , Cardiovascular Agents/therapeutic use , Humans , Infant , Ivabradine , Male , Tachycardia, Ectopic Junctional/etiology , Tachycardia, Ectopic Junctional/physiopathology
SELECTION OF CITATIONS
SEARCH DETAIL